Shao Ling Zhang
Montreal Diabetes Research Center, Canada
Zhang obtained her Bachelor of Medicine (1989) from Shanghai Medical University, China. Then, she obtained her MSc (1999) and PhD (2002, recipient of a CIHR doctoral award) degrees from the Université de Montréal in the Department of Biomedical Sciences under the supervision of Dr John Chan (CRCHUM). With the support of a CIHR research fellowship (2002-2004), she finished her post-doctoral training at Massachusetts General Hospital at Harvard Medical School under the supervision of Dr Julie Ingelfinger. In October 2004, she was recruited back to CRCHUM and MDRC as an independent investigator. She was the recipient of Young Investigator Award from CIHR-KRESCEN (Kidney Research Scientist Core Education and National Training; 2005-2008) program and Chercheur-boursier junior I du FRSQ (2005-2009). Currently, she is a scholar of Chercheur-boursier junior II du FRSQ (2010-2013). With financial supports by the CIHR, Kidney Foundation of Canada, FRSQ, Fondation du CHUM, Leader Opportunity Fund of Canada Foundation for Innovation (CFI) and Heart Stroke Foundation of Quebec, her research program has been focused on the area of "Maternal Diabetes and Perinatal Programming of Kidney and Cardiovascular Diseases".
Role of reactive oxygen species (ROS) in maternal diabetes-induced perinatal programming Role of Angiotensin Converting Enzyme-2 (ACE2) gene expression on maternal diabetes-induced perinatal programming of hypertension